CN1274358C - Specific medicine for treating cancer and preparing process - Google Patents
Specific medicine for treating cancer and preparing process Download PDFInfo
- Publication number
- CN1274358C CN1274358C CNB2003101213863A CN200310121386A CN1274358C CN 1274358 C CN1274358 C CN 1274358C CN B2003101213863 A CNB2003101213863 A CN B2003101213863A CN 200310121386 A CN200310121386 A CN 200310121386A CN 1274358 C CN1274358 C CN 1274358C
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- restrains
- cancer
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a special medicine for treating various kinds of cancer and a preparation method thereof. The medicine is formed by the combination of a sovereign medicine and an auxiliary medicine (a medicinal guide), wherein the sovereign medicine has principal components of euphorbia zedoary, artificial bezoar, common andrographis herb, tortoise plastron, dedyotic diffusa, etc., and the auxiliary medicine has principal components of Herba Agrimoniae, angelica, notoginseng, fructus, hemlock parsley, pilose asiabell root, curcuma aromatica, etc. The curative effect of the medicine of the present invention is conspicuous, and total effective rate of treating liver cancer, gastric cancer, intestinal cancer, lung cancer, esophagus cancer, mammary cancer, lymph cancer, etc. of the present invention can reach over 80%.
Description
The present invention relates to a kind of specific medicament that is used for the treatment of various cancers and preparation method thereof.
Cancer is one of present serious threat human life and healthy malignant disease, and cancer expert and knowledgeable people are controlled in the research of curing cancer drug in countries in the world, have spent a large amount of financial resources, material resources, can still not draw gratifying result.The various kinds of drug of existing treatment cancer, effect is not satisfactory, and in various degree deposit side effect.
The objective of the invention is for a kind of specific medicament for the treatment of cancer is provided.This medicine is divided into principal agent and auxiliary medicine (guiding drug), and is all formulated by Chinese medicine, has no side effect, and all kinds of cancers are had very outstanding treatment, alleviation and preventive effect.
In order to achieve the above object, drug main of the present invention will adopt, with malicious merit poison, liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, soothing the channels and quicking the network vessels, invigorating spleen to remove dampness, hard masses softening and resolving, heat-clearing and toxic substances removing, consolidate and set upright " principle, in treatment all kinds of cancers and clinical practice, obtained very obvious effects.
The combination ingredient and the configuration proportion thereof of principal agent medicine of the present invention following (calculating) by drug weight:
The Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 9 gram Rhizoma Curcumae 7 grams
Artificial Calculus Bovis's 12 gram Herba Andrographis 7 grams
Carapax et Plastrum Testudinis 12 gram Rhizoma Coptidis 5 grams
Squama Manis 15 gram Herba Taraxacis 10 grams
The Herba Hedyotidis Diffusae 20 gram Rhizoma Atractylodis Macrocephalaes 10 grams
The Herba Scutellariae Barbatae 20 gram Rhizoma Pinelliaes 9 grams
The Herba Solani Nigri 20 gram Radix Rehmanniae 7 grams
Rhizoma Dioscoreae Bulbiferae 5 gram Spica Prunellaes 7 grams
Concha Ostreae 5 gram Rhizoma Corydalis 12 grams
Rhizoma sparganic 7 grams
The combination ingredient of auxiliary medicine (guiding drug) and configuration proportion thereof (calculating) by drug weight:
Herba Agrimoniae 15 gram Radix Angelicae Sinensis 10 grams
Radix Notoginseng 5 gram Fructus Zanthoxylis 5 grams
Rhizoma Chuanxiong 10 gram Radix Codonopsis 15 grams
Radix Curcumae 10 gram Pericarpium Citri Reticulataes 10 grams
Radix Bupleuri 15 grams
Embodiment
1, the preparation method of principal agent:
Principal agent of the present invention has 19 kinds of prepared from traditional Chinese medicines and forms, and gross weight is 199 grams, and wherein the weight of each composition is:
The Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 9 gram Rhizoma Curcumae 7 grams
Artificial Calculus Bovis's 12 gram Herba Andrographis 7 grams
Carapax et Plastrum Testudinis 12 gram Rhizoma Coptidis 5 grams
Squama Manis 15 gram Herba Taraxacis 10 grams
The Herba Hedyotidis Diffusae 20 gram Rhizoma Atractylodis Macrocephalaes 10 grams
The Herba Scutellariae Barbatae 20 gram Rhizoma Pinelliaes 9 grams
The Herba Solani Nigri 20 gram Radix Rehmanniae 7 grams
Rhizoma Dioscoreae Bulbiferae 5 gram Spica Prunellaes 7 grams
Concha Ostreae 5 gram Rhizoma Corydalis 12 grams
Rhizoma sparganic 7 grams
Manufacture method: after above-mentioned every medicine pulverized in proportion and being ground into medicated powder, stir standby getting final product in the bottle of packing into.
2, the preparation method of auxiliary medicine (guiding drug):
Auxiliary medicine of the present invention (guiding drug) has 9 kinds of prepared from traditional Chinese medicines and forms, and gross weight is 95 grams, and wherein the weight of each composition is:
Herba Agrimoniae 15 gram Radix Angelicae Sinensis 10 grams
Radix Notoginseng 5 gram Fructus Zanthoxylis 5 grams
Rhizoma Chuanxiong 10 gram Radix Codonopsis 15 grams
Radix Curcumae 10 gram Pericarpium Citri Reticulataes 10 grams
Radix Bupleuri 15 grams
Manufacture method: above-mentioned 9 kinds of Chinese herbal medicine are proportioned, insert in the medicinal cupping, add four parts water again, boiled with the slow fire heating, it is standby to fry in shallow oil into medicinal liquid.
Instructions of taking: principal agent and auxiliary medicine (guiding drug) are simultaneously oral, take principal agent one soup ladle at every turn, and send down with decoction [auxiliary medicine (guiding drug)], can take every day three times.
In order to alleviate cancer patient's misery, reach aim of alleviating pain, when taking above-mentioned oral drugs, can use the pain relieving medicinal liquid to smear in patient's cancer lesion.
The manufacture method of external-use analgesic:
External-use analgesic has 5 kinds of prepared from traditional Chinese medicines to form, and gross weight is 26 grams, and wherein the weight of each composition is:
Olibanum 5 gram Myrrhas 5 grams
Borax 10 gram Radix Et Rhizoma Rhei 3 grams
Borneolum Syntheticum 3 grams
Manufacture method: earlier above-mentioned 5 kinds of Chinese medicines are mixed in proportion, place container, add the ethanol that 200 grams 70 are spent again in container, medicine soaks two days later in ethanol, promptly can be used for embrocating patient's sore spot (the part person of festering forbidding).
The medicine cost that the present invention uses is low, making is easy, evident in efficacy.Clinical trial certificate behind oral principal agent and auxiliary medicine (guiding drug), can reach more than 80% the total effective rate of diseases such as hepatocarcinoma, gastric cancer, intestinal cancer, pulmonary carcinoma, esophageal carcinoma, laryngeal carcinoma, breast carcinoma, lymphatic cancer, bladder cancer, cancer of pancreas.
Claims (3)
1, the medicine of treatment cancer, it is characterized in that this medicine is formed by principal agent and two groups of Chinese medicine composition of auxiliary medicine, the compositions and the weight ratio thereof of principal agent are: the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 9 grams, Rhizoma Curcumae 7 grams, artificial Calculus Bovis's 12 grams, Herba Andrographis 7 grams, Carapax et Plastrum Testudinis 12 grams, Rhizoma Coptidis 5 grams, Squama Manis 15 grams, Herba Taraxaci 10 grams, Herba Hedyotidis Diffusae 20 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Herba Scutellariae Barbatae 20 grams, the Rhizoma Pinelliae 9 grams, Herba Solani Nigri 20 grams, the Radix Rehmanniae 7 grams, Rhizoma Dioscoreae Bulbiferae 5 grams, Spica Prunellae 7 grams, Concha Ostreae 5 grams, Rhizoma Corydalis 12 grams, rhizoma sparganic 7 grams, after principal agent made up in described ratio, pulverize was made; The compositions and the weight ratio thereof of auxiliary medicine are: Herba Agrimoniae 15 restrains, Radix Angelicae Sinensis 10 restrains, Radix Notoginseng 5 restrains, Fructus Zanthoxyli 5 restrains, Rhizoma Chuanxiong 10 restrains, Radix Codonopsis 15 restrains, Radix Curcumae 10 restrains, Pericarpium Citri Reticulatae 10 restrains, Radix Bupleuri 15 restrains, and after auxiliary medicine made up in described ratio, decoction formed.
2, medicine according to claim 1 is characterized in that the preparation method of principal agent is: after described principal agent compositions is made up by described weight ratio, with its pulverizing, and be developed into Powderedly, powder is stirred gets final product then.
3, medicine according to claim 1 is characterized in that the preparation method of auxiliary medicine is: after described auxiliary medicine compositions is made up by described weight ratio, insert in the medicinal cupping, add four parts water again, boiled with the slow fire heating, fried one-tenth medicinal liquid gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101213863A CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101213863A CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1546158A CN1546158A (en) | 2004-11-17 |
| CN1274358C true CN1274358C (en) | 2006-09-13 |
Family
ID=34338446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101213863A Expired - Fee Related CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1274358C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070160696A1 (en) * | 2006-01-11 | 2007-07-12 | The Procter & Gamble Company | Compositions and methods useful for prevention or treatment of respiratory illness |
| CN100389748C (en) * | 2006-02-24 | 2008-05-28 | 陕西师范大学 | Chemotherapeutic emulsion for treating rectum cancer |
| CN1943648B (en) * | 2006-10-18 | 2012-03-07 | 赵正福 | A plant medicine for treatment of primary hepatic carcinoma and its preparation method and use |
| CN101869667B (en) * | 2009-04-21 | 2011-07-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
| CN101543612B (en) * | 2009-05-12 | 2012-07-04 | 王秋贤 | Chinese medicament for treating malignant lymphoma |
| CN102727854B (en) * | 2012-07-05 | 2013-08-28 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN104383358A (en) * | 2014-11-03 | 2015-03-04 | 山东瑞康生命科技有限公司 | Preparation method of traditional Chinese medicine preparation for treating tongue cancer |
| CN104800510A (en) * | 2015-05-07 | 2015-07-29 | 王小华 | Traditional Chinese medicine composition for treating stomach cancer |
| CN105687664A (en) * | 2016-03-04 | 2016-06-22 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine condensed pill for treating head and neck neoplasms and preparation method thereof |
| CN109248236A (en) * | 2017-07-14 | 2019-01-22 | 浏阳市利美免疫力修复中心有限公司 | A kind of Chinese medicine composition for treating liver tumour |
-
2003
- 2003-12-16 CN CNB2003101213863A patent/CN1274358C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1546158A (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1162171C (en) | Gynopathy treating traditional Chinese medicine | |
| CN1947790A (en) | Medicine for treating paralysis and its prepn. method | |
| CN1943683A (en) | An external use medicinel and beauty composition for treatment of and preventing chloasma | |
| CN1274358C (en) | Specific medicine for treating cancer and preparing process | |
| CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1077789C (en) | Bathing preparation and making method thereof | |
| CN101036779A (en) | Composite medicine for treating hepatopathy and its preparing process | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN101336998B (en) | Traditional Chinese medicine for treating whelk | |
| CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN1058911A (en) | The compound method of capsule for curing tumour | |
| CN1876148A (en) | A Chinese medicinal composition for replenishing kidney and strengthening bone and preparation method thereof | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN1111045C (en) | Chewing medicine for treating facial paralysis and its preparing process | |
| CN1074292C (en) | Cancer treating medicine capsule | |
| CN1589839A (en) | Stasis transforming pain relieving particle agent and its preparation method | |
| CN1179953A (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN1088450A (en) | The excellent blood fat reducing of preparation of treatment hyperlipidemia | |
| CN1470271A (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1334114A (en) | Chinese medicine for treating mastoplasia | |
| CN1813876A (en) | Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease | |
| CN1336221A (en) | Angiocardiopathy treating traditional Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060913 Termination date: 20101216 |